Biocon Limited (NSE:BIOCON)
391.50
-0.15 (-0.04%)
Sep 11, 2026, 3:15 PM IST
Biocon Revenue
Biocon had revenue of 43.36B INR in the quarter ending June 30, 2026, with 10.00% growth. This brings the company's revenue in the last twelve months to 173.21B, up 9.83% year-over-year. In the fiscal year ending March 31, 2026, Biocon had annual revenue of 169.27B with 10.91% growth.
Revenue (ttm)
173.21B
Revenue Growth
+9.83%
P/S Ratio
3.65
Revenue / Employee
10.53M
Employees
16,447
Market Cap
632.66B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 169.27B | 16.65B | 10.91% |
| Mar 31, 2025 | 152.62B | 5.06B | 3.43% |
| Mar 31, 2024 | 147.56B | 35.82B | 32.05% |
| Mar 31, 2023 | 111.74B | 29.90B | 36.54% |
| Mar 31, 2022 | 81.84B | 10.41B | 14.57% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Dishman Carbogen Amcis | 29.01B |
| Anthem Biosciences | 20.07B |
| OneSource Specialty Pharma | 15.43B |
| Concord Biotech | 11.08B |
| Blue Jet Healthcare | 8.86B |
| Supriya Lifescience | 8.73B |
| Panacea Biotec | 6.73B |
| Zota Health Care | 6.09B |
Biocon News
- 3 days ago - Biocon Signs Brazil Pertuzumab Deal With Bahiafarma And Bionovis - Nasdaq
- 14 days ago - Don’t taunt me as billionaire: Kiran Mazumdar Shaw - The Times of India
- 5 weeks ago - Biocon Transcript: Q1 26/27 - Transcripts
- 5 weeks ago - Biocon Quarterly report: Q1 2027 - Filings
- 5 weeks ago - Biocon Slides: Q1 2027 - Filings
- 5 weeks ago - Biocon Q1 net profit surges fourfold to Rs 141 cr - The Times of India
- 5 weeks ago - India's Biocon posts more than fourfold jump in quarterly profit on strong biosimilars growth - Reuters
- 6 weeks ago - Roche sues Biocon over proposed breast-cancer drug copy - Reuters